Live Cell Imaging of Mitochondria and Actin Dynamics During Synaptogenesis. Awarded $100,000 over 2 years.

Reconstruction of Human Blood-brain-barrier in a Vascularized Brain Organoid Model for in vitro Study of Brain Vascular Disease. Awarded $100,000 over 2 years.

Does neuronal infection by SARS-CoV-2 resemble hallmarks of early-stage neurodegeneration? Awarded $100,000 over 2 years.

Targeting Astrocytes to Enhance Synaptic Plasticity and Repair. Awarded $100,000 over 2 years.

Mechanistic studies into the cognitive rescue effect of pioglitazone in chronic TBI. Awarded $100,000 over 2 years.

Mechanisms of enhanced autophagy protecting healthy aging of neural stem cells. Awarded $100,000 over 2 years.

Functional Significance of DEK in Alzheimer’s Disease and Age-Related Dementias. Awarded $100,000 over 2 years.

Cell type-specific molecular and epigenetic impacts of stress on aminergic neurons. Awarded $100,000 over 2 years.

Inhibition of Drp1 using a selective Drp1 peptide inhibitor for treatment of alpha-synuclein associated Parkinson’s Disease. Awarded $100,000 over 2 years.

Single Cell Characterization of Epigenetic Mechanisms Underlying Cocaine Craving. Awarded $100,000 over 2 years.

Examining and identifying function and role of LPHN3 in ADHD. Awarded $100,000 over 2 years.

Identifying the genetic risk underlying poor cognitive recovery after traumatic brain injury. Awarded $100,000 over 2 years.

Developing a neuron replacement therapy to improve breathing, motor function and survival in neurodegenerative disease. Awarded $100,000 over 2 years.

Exploring the role of the oncogene Dek as a novel player in Alzheimer's disease. Awarded $100,000 over 2 years.

Non-invasive IPSC-based Therapies for Treatment of Neurodegenerative Diseases. Awarded $100,000 over 2 years.

Proteomic and genomic investigation of PSD-95 protein-protein interactions in schizophrenia. Awarded $100,000 over 2 years.